IL2 and sarcoidosis: Sarcoidosis is characterized as a Th1- (81) and more recently a Th17-mediated disease (61, 82), based on the accumulation of INF-γ, IL-2, and IL17-producing Th cells in the lungs of patients with active sarcoidosis (44, 61, 82–84).